HSK39297

· Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for HSK39297, covering 2024-12-20 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia [Phase 3]